Fundz

Hcw Biologics reported raising $4 Million in an initial SEC Form D filing, from an offering of $4 Million

PUBLIC · HCWBJun 08, 2026

Amount Raised

$4 Million

$4 Million sold, per SEC Form D (first sale May 21, 2026)

Round Type

Venture

MiramarBiotechnologyHealth CareTherapeuticsBiopharma

Who to call at HCW Biologics, and when

A new round usually means HCW Biologics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day HCW Biologics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at HCW Biologics, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

HCW Biologics

Location

2929 N COMMERCE PKWY

Miramar, Florida, United States

About

HCW Biologics is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between chronic, low-grade inflammation, and age-related diseases, such as cancer, cardiovascular diseases, diabetes, neurodegenerative diseases, autoimmune diseases, as well as other conditions such as long-haul COVID-19.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment HCW Biologics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsHing W., Executive Officer, Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for HCW Biologics's next move

See what Strategic adds

HCW Biologics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.